Management of Epilepsy During Pregnancy: Evidence-based Strategies

Overview

Journal Future Neurol

Specialty Neurology

Date 2019 Feb 19

PMID 30774557

Authors

Swapna Putta

Page B Pennell

Affiliations

Soon will be listed here.

Abstract

Child-bearing years are often the most precarious management period in the life of a woman with epilepsy. This article reviews the results of many different studies with findings that enable the healthcare team to make confident decisions and recommendations during these critical periods. Preconceptional planning, effective contraception and folic acid supplementation are important fundamentals in preparation for pregnancy. There is growing evidence to avoid valproic acid use during the child-bearing years. Emerging data on congenital malformations and neurocognitive outcomes are available for some of the second-generation antiepileptic drugs and appear reassuring for lamotrigine and levetiracetam. Also reviewed are the benefits of postpartum drug tapers and favorable breastfeeding facts. Counseling the mother and her family on medication choices enables the healthcare team to implement informed decisions that are beneficial for the mother and child.

References

Honein M, Paulozzi L, Cragan J, Correa A . Evaluation of selected characteristics of pregnancy drug registries. Teratology. 1999; 60(6):356-64. DOI: 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.0.CO;2-B. View

Yerby M . Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology. 2000; 55(5 Suppl 1):S21-31; discussion S54-8. View

Adab N, Jacoby A, Smith D, Chadwick D . Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2000; 70(1):15-21. PMC: 1763464. DOI: 10.1136/jnnp.70.1.15. View

Meador K . Neurodevelopmental effects of antiepileptic drugs. Curr Neurol Neurosci Rep. 2002; 2(4):373-8. DOI: 10.1007/s11910-002-0013-6. View

Kaaja E, Kaaja R, Hiilesmaa V . Major malformations in offspring of women with epilepsy. Neurology. 2003; 60(4):575-9. DOI: 10.1212/01.wnl.0000044157.28073.dc. View

Katz J, Devinsky O . Primary generalized epilepsy: a risk factor for seizures in labor and delivery?. Seizure. 2003; 12(4):217-9. DOI: 10.1016/s1059-1311(02)00288-1. View

Wilson R, Davies G, Desilets V, Reid G, Summers A, Wyatt P . The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2003; 25(11):959-73. DOI: 10.1016/s1701-2163(16)30248-1. View

Fried S, Kozer E, Nulman I, Einarson T, Koren G . Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf. 2004; 27(3):197-202. DOI: 10.2165/00002018-200427030-00004. View

Adab N, Tudur S, Vinten J, Williamson P, Winterbottom J . Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev. 2004; (3):CD004848. DOI: 10.1002/14651858.CD004848. View

10.

Meador K, Zupanc M . Neurodevelopmental outcomes of children born to mothers with epilepsy. Cleve Clin J Med. 2004; 71 Suppl 2:S38-41. DOI: 10.3949/ccjm.71.suppl_2.s38. View

11.

Pennell P . Pregnancy in women who have epilepsy. Neurol Clin. 2004; 22(4):799-820. DOI: 10.1016/j.ncl.2004.07.004. View

12.

Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J . The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004; 75(11):1575-83. PMC: 1738809. DOI: 10.1136/jnnp.2003.029132. View

13.

Sahoo S, Klein P . Maternal complex partial seizure associated with fetal distress. Arch Neurol. 2005; 62(8):1304-5. DOI: 10.1001/archneur.62.8.1304. View

14.

. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology. 2005; 66(3):354-60. DOI: 10.1212/01.wnl.0000195888.51845.80. View

15.

Sidhu J, Job S, Singh S, Philipson R . The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006; 61(2):191-9. PMC: 1885007. DOI: 10.1111/j.1365-2125.2005.02539.x. View

16.

Pennell P . EURAP outcomes for seizure control during pregnancy: useful and encouraging data. Epilepsy Curr. 2007; 6(6):186-8. PMC: 1783493. DOI: 10.1111/j.1535-7511.2006.00140.x. View

17.

Tomson T, Battino D . Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet. 2007; 46(3):209-19. DOI: 10.2165/00003088-200746030-00002. View

18.

Kaplan P, Norwitz E, Ben-Menachem E, Pennell P, Druzin M, Robinson J . Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav. 2007; 11(3):283-91. DOI: 10.1016/j.yebeh.2007.08.012. View

19.

Pennell P, Peng L, Newport D, Ritchie J, Koganti A, Holley D . Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 2007; 70(22 Pt 2):2130-6. PMC: 3589527. DOI: 10.1212/01.wnl.0000289511.20864.2a. View

20.

Pennell P . Hormones, seizures, and lamotrigine: Oh, my!. Epilepsy Curr. 2008; 8(1):8-10. PMC: 2238645. DOI: 10.1111/j.1535-7511.2007.00217.x. View